By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

The 2023 decision to upend affirmative action, coupled with ongoing federal funding cuts, may threaten representation of Black leaders in the pharma industry.